InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Eckhardt Sue Gail, Director. Director active across 2 companies, notably Exelixis, INC.. In total, 10 filings have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €845k. History available since 16 September 2022. The latest transaction was filed on 27 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Eckhardt Sue Gail
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
8,367 股0Common StockSEC:0000939767-26-000081:0
3,856 股@ US$43.790.0012% mcap8.4% 占其流量Common StockSEC:0000939767-26-000025:0
18,834 股@ US$42.740.0061% mcap41.6% 占其流量Common StockSEC:0000939767-25-000099:0
9,812 股0Common StockSEC:0000939767-25-000087:0
7,712 股@ US$23.249.2% 占其流量Common StockSEC:0000939767-25-000020:0
4,000 股0Common StockSEC:0000950170-24-070713:0
18,838 股0Common StockSEC:0000939767-24-000096:0
15,424 股0Common StockSEC:0000939767-24-000010:0
4,000 股0Common StockSEC:0001209191-23-033720:0
8,000 股0Common StockSEC:0001209191-22-050551:0
10 条申报中的 10 条
About Eckhardt Sue Gail
Eckhardt Sue Gail is a Director at EXELIXIS, INC., a biotechnology company. In her role, she contributes to the strategic direction and oversight of the company's operations. Sue Gail brings significant experience in the sector, thus supporting innovation and growth at EXELIXIS.
